表紙:動物向け幹細胞治療の世界市場:2020~2027年
市場調査レポート
商品コード
991637

動物向け幹細胞治療の世界市場:2020~2027年

Global Animal Stem Cell Therapy Market - 2020-2027

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.03円
動物向け幹細胞治療の世界市場:2020~2027年
出版日: 2021年02月24日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

動物向け幹細胞治療は、動物の平均余命を延ばします。近年、関節炎、変形性関節症、動物の靭帯や腱の損傷など、さまざまな健康問題の症例が大幅に増加しています。これらの要因は、世界の動物向け幹細胞治療市場の発展を支えています。

COVID-19パンデミックは、COVID-19パンデミックのワクチン開発の中で動物向け幹細胞治療への注目が低下したことにより、2020年に動物向け幹細胞治療市場に衝撃を与えました。したがって、2020年における動物幹細胞治療の市場規模は低下しました。しかし、予測期間中には市場の適度な成長が予測されています

当レポートでは、世界の動物向け幹細胞治療市場について調査分析し、市場の概要、市場成長への影響要因、各セグメント・地域別による市場規模と前年比成長、および主要企業などについて分析しています。

目次

第1章 世界の動物向け幹細胞治療市場:調査範囲・手法

  • 調査手法
  • 調査目的・範囲

第2章 世界の動物向け幹細胞治療市場:市場の定義・概要

第3章 世界の動物向け幹細胞治療市場:エグゼクティブサマリー

  • 市場内訳:アプリケーション別
  • 市場内訳:エンドユーズ別
  • 市場内訳:地域別

第4章 世界の動物向け幹細胞治療市場:市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 影響分析

第5章 世界の動物向け幹細胞治療市場:業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • バリューチェーン分析
  • PEST分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ
  • 特許動向

第6章 世界の動物向け幹細胞治療市場:COVID-19分析

  • 市場におけるCovid-19の分析
    • COVID-19以前の市場シナリオ
    • 現在の市場シナリオ
    • COVID-19以降または将来のシナリオ
  • Covid-19期間中の価格ダイナミクス
  • 需要と供給のスペクトル
  • パンデミック期間中の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の動物向け幹細胞治療市場:アプリケーション別

  • イントロダクション
  • 市場規模分析および前年比成長分析(%):アプリケーション別
  • 市場魅力指数:アプリケーション別
    • ネコ
    • ウマ
    • その他

第8章 世界の動物向け幹細胞治療市場:エンドユーズ別

  • イントロダクション
  • 市場規模分析および前年比成長分析(%):エンドユーズ別
  • 市場魅力指数:エンドユーズ別
    • 獣医病院
    • 獣医クリニック
    • 研究機関

第9章 世界の動物向け幹細胞治療市場:地域別

  • イントロダクション
    • 市場規模分析および前年比成長分析(%):地域別
    • 市場魅力指数:地域別
  • 北米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析および前年比成長分析(%):アプリケーション別
    • 市場規模分析および前年比成長分析(%):エンドユーズ別
    • 市場規模分析および前年比成長分析(%):国別
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第10章 世界の動物向け幹細胞治療市場:競合情勢

  • 競合シナリオ
  • 市場ポジショニング/シェア分析
  • 合併と買収の分析

第11章 企業プロファイル

  • U.S. Stem Cell, Inc
    • 企業概要
    • 製品ポートフォリオ・説明
    • 主なハイライト
    • 財務概要
  • J-ARM
  • Celavet Inc.
  • VetCell Therapeutics
  • Medivet Biologics LLC
  • Animal Cell Therapies
  • Kintaro Cells Power
  • VETSTEM BIOPHARMA
  • Magellan Stem Cells
  • Animal Stem Care

第12章 世界の動物向け幹細胞治療市場:重要考察

第13章 世界の動物向け幹細胞治療市場:DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次

Market Overview

Animal stem cell therapy involves usage of animal's stem cell for the treatment of a certain disease or disorder. The stem cell has an ability to divide and differentiate cell, with particular function useful for fixing body tissues damaged by disease or injury. The animal stem cell therapy process consist of three steps which include compilation of stem cell sample from animals and arranging the sample to concentrate the stem cells. Finally, the therapy involves transferring the stem cells into the affected site for treatment. This therapy increases the expectancy of life in animals, minimizing the side effects. It is available for the treatment of degenerative joint disorders, arthritis, and tendon and ligaments injuries in animals. Stem cell therapy is often used to treat cats, dogs, and horses. However, the recent developments made it possible to use animal stem cell therapy in pig, tiger, and others. The animal stem cell therapy is studied in treatment of the kidney, inflammatory bowel, liver, heart and immune-mediated diseases respectively.

The global animal stem cell therapy market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).

Market Dynamics

Expanding prevalence of infection in animals with increasing populace and to develop the creature's personal satisfaction. Alongside, the expanding government subsidizing for the and quick endorsements of FDA and assurance of creatures contributing towards the rapid development of the creature undifferentiated cell treatment.

Increasing prevalence of disease in animals

Increasing prevalence of disease in animals to increase the animal's quality of life, the companies concentrate shifting towards animal stem cell therapies. Moreover, the increasing government funding for the safety of animals and fast approvals of FDA for therapy contributing towards the growth of the animal stem cell therapy. The research in animal stem cells offers great potential for understanding fundamental mechanisms of animal development; offering the great opportunities to treat a range of diseases and conditions in animals. This therapy is increasingly recognized as important translational models of human disease for treatment. All these factors perform as drivers for the robust growth of the animal stem cell therapy market.

Various benefits associated with animal stem cell therapy

Animal stem cell therapy is gaining huge traction these days, backed by its ability to use animal's stem cell and extend treatment for their disease or disorders. This therapy increases the life expectancy of animals. In recent years, there is significant growth in the cases of various health issues such as arthritis, degenerative joint disorders, and ligaments and tendon injuries in animals. This factor is supporting the development of the global animal stem cell therapy market.

COVID-19 Impact Analysis

The COVID-19 pandemic has jolted the animal stem cell therapy market in 2020, backed by the decline in the focus on animal stem cell therapy amidst the development of vaccines for the COVID-19 pandemic. Therefore, the market value of animal stem cell therapy has declined in 2020; however, a modest growth can be expected in the market during the forecast period.

Segment Analysis

  • Based on the application, the animal stem cell therapy market has been classified dog, cat, horse and others
  • Dog segment is expected to be the fastest growing segment

The dog segment is anticapted to grow with highest CAGR in the global animal stem cell therapy market over the forecast period, owing to factors such as increasing number of dog owners, which are inclining towards treatment options having no adverse effects on animals. Moreover, the majority of the vendors in the market are targeting dog segment for investments in the research and development for animal stem cell therapy.

  • Based on the end user, the animal stem cell therapy market has been classified into veterinary hospitals, veterinary clinics and research organizations
  • Research organizations segment is anticapted to boost the growth rate of the market

Increasing investment in R&D activities in the animal stem cell therapy market is one of the major factor for the growth of the global market. Key purpose of these activities is to track the possibility of using this technology in the treatment of animals apart from dogs, cats, and horses. Therefore, the global animal stem cell therapy market is expected to gather remarkable opportunities in the upcoming years.

Geographical Analysis

Based on geography, the study analyzes the animal stem cell therapy market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is anticipated to hold largest share in the global animal stem cell therapy market

North America held a dominant position in the global animal stem cell therapy market due to the increased awareness rate of the therapy. The U.S. characterizes the largest market share in the North America market due to the high demand for the therapy. Asia-Pacific and Europe are showing a considerable growth rate during the forecasted period owing to the growing adoption of the animal stem cell therapy. This market is in underdeveloped countries, compared to the developed countries.

Competitive Landscape

The animal stem cell therapy market is highly competitive, owing to the presence of big food brands. The key animal stem cell therapy players which are contributing to the growth of the global market include J-ARM, U.S. Stem Cell, Inc, Celavet Inc., VetCell Therapeutics, Medivet Biologics LLC, Animal Cell Therapies, Kintaro Cells Power, VETSTEM BIOPHARMA, Magellan Stem Cells, Animal Stem Care, among others. The major players are adopting new product launch and expansion strategies for global growth in the animal stem cell therapy market.

U.S. Stem Cell, Inc.:

U.S. Stem Cell, Inc. development, and subject to regulatory approval, and the commercialization of autologous cell therapies, especially for the treatment of chronic and acute heart damage. The company's MyoCell, deals with the clinical therapy intended to improve cardiac function in chronic heart failure patients. The company was founded in 1999 and is headquartered in Sunrise, FL.

Product Portfolio: The Company's portfolio comprises myocell, adipocell, and clinical trials among others

Why Purchase the Report?

  • Visualize the animal stem cell therapy market segmentation composition by application, end user and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the animal stem cell therapy market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of animal stem cell therapy market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global animal stem cell therapy market report would provide access to an approx. 57 market data table, 57 figures and 250 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Animal Stem Cell Therapy Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Animal Stem Cell Therapy Market - Market Definition and Overview

3. Global Animal Stem Cell Therapy Market - Executive Summary

  • 3.1. Market Snippet by Application
  • 3.2. Market Snippet by End Use
  • 3.3. Market Snippet by Region

4. Global Animal Stem Cell Therapy Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of disease in animals
      • 4.1.1.2. Various benefits associated with animal stem cell therapy
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness
    • 4.1.3. Impact Analysis

5. Global Animal Stem Cell Therapy Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. Global Animal Stem Cell Therapy Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Animal Stem Cell Therapy Market - By Application

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 7.3. Market Attractiveness Index, By Application Segment
    • 7.3.1. Dog*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. CAT
    • 7.3.3. Horse
    • 7.3.4. Others

8. Global Animal Stem Cell Therapy Market - By End Use

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Use Segment
  • 8.3. Market Attractiveness Index, By End Use Segment
    • 8.3.1. Veterinary hospitals*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Veterinary clinics
    • 8.3.3. Research organizations

9. Global Animal Stem Cell Therapy Market - By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Use
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Use
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Use
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Use
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Use
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Global Animal Stem Cell Therapy Market - Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Global Animal Stem Cell Therapy Market- Company Profiles

  • 11.1. U.S. Stem Cell, Inc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. J-ARM
  • 11.3. Celavet Inc.
  • 11.4. VetCell Therapeutics
  • 11.5. Medivet Biologics LLC
  • 11.6. Animal Cell Therapies
  • 11.7. Kintaro Cells Power
  • 11.8. VETSTEM BIOPHARMA
  • 11.9. Magellan Stem Cells
  • 11.10. Animal Stem Care

LIST NOT EXHAUSTIVE

12. Global Animal Stem Cell Therapy Market - Premium Insights

13. Global Animal Stem Cell Therapy Market - DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us